ImmunoPrecise to Lead Scientific Round-table Discussion and Poster Session at hubXchange’s European Antibody Therapeutics event. At hubXchange’s European Antibody Therapeutics event, held in Munich on March 21st, Dr. Debby Kruijsen will lead a round-table discussion entitled “Implementing discovery strategies to value the therapeutic potential of lead antibody candidates” while Nienke Smits will present a poster entitled …
IPA Featured Services
B-Cell Select mAb Discovery
ImmunoPrecise is excited to offer custom B-Cell Select Antibody Discovery. This proprietary technology allows for selection of target specific B-cells from any tissue in a variety of animal species.
Learn More: B-Cell Select
Our phage display approach is based on building custom immune libraries from multiple species, or the selection of antigen specific recombinant antibody fragments from our proprietary human or llama phage libraries.
Learn More: Phage Display
Along with traditional methods of hybridoma development, Rapid Prime is ImmunoPrecise’s proprietary custom mAb development service. This quick and effective immunization strategy coupled with Single-Step cloning, saves weeks in development time. Positive hybridoma clones are identified in 32 days.
Learn More: Hybridoma Development
IPA offers rabbit monoclonal development. This proprietary technology allows for the screening of the immune repertoire of the rabbit, creating the power to select the desired antibody directly from the B cells using our B-Cell Select Antibody Discovery platform.
Learn More: Rabbit mAbs
Our proprietary expression technology is designed to deliver fast and large-scale production of (mammalian) recombinant proteins and antibodies for research and pre-clinical applications.
Learn More: Antibody Manufacturing